Cost-effectiveness of SAPIEN 3 transcatheter aortic valve implantation Versus Surgical aortic valve replacement in German severe aortic stenosis patients at Low …

KH Kuck, R Leidl, L Frankenstein, T Wahlers… - Advances in …, 2023 - Springer
Introduction In the randomized PARTNER 3 trial, transcatheter aortic valve implantation
(TAVI) with the SAPIEN 3 device significantly reduced a composite of all-cause death …

Infections associated with cardiac electronic implantable devices: economic perspectives and impact of the TYRX™ antibacterial envelope

G Boriani, M Vitolo, DJ Wright, M Biffi, B Brown… - Ep …, 2021 - academic.oup.com
The occurrence of cardiac implantable electronic devices (CIED) infections and related
adverse outcomes have an important financial impact on the healthcare system, with …

Mechanical dyssynchrony as a selection criterion for cardiac resynchronization therapy: Design of the AMEND‐CRT trial

A Puvrez, J Duchenne, E Donal, J Gorcsan III… - ESC heart …, 2024 - Wiley Online Library
Aims One third of patients do not improve after cardiac resynchronization therapy (CRT).
Septal flash (SF) and apical rocking (ApRock) are deformation patterns observed on …

Economic evaluation of remote monitoring of patients with an implantable cardiac defibrillator (REMOTE-CIED study)

G de Graaf, I Timmermans, M Meine… - Journal of …, 2024 - journals.sagepub.com
Introduction Remote patient monitoring (RPM) of heart failure patients has the potential to
reduce healthcare resource use and costs, but current evidence has been inconclusive. This …

[图书][B] Tod und Tabu in der Pandemie: kulturökonomische Lehren aus der Covid-19-Politik

E Mohr - 2023 - library.oapen.org
Krisen erschüttern das gesellschaftliche Denken über Leben und Tod. In der Covid-19-
Pandemie wurde die Individualität des Menschen selbst im Sterben durch das Tabu des …

Cardiac resynchronisation with defibrillator in HF: benefits at a cost

M Hadwiger - PharmacoEconomics & Outcomes News, 2020 - Springer
This is the main finding of a study from Germany that used a Markov model to evaluate the
cost effectiveness of CRTD versus CRT-P for the treatment of a hypothetical cohort of 1000 …